Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Laura M Dember

Showing results (61-70 of 140) with videos related to

Pageof 14
Sort By:
Kidney International Reports|October 11, 2022
Efficacy, Safety, and Tolerability of Oral Furosemide Among Patients Receiving Hemodialysis: A Pilot StudyJennifer E Flythe, Magdalene M Assimon, Matthew J Tugman, et al.
British Journal of Clinical Pharmacology|May 4, 2026
Impact of empiric potassium supplementation on mortality, sudden cardiac arrest and stroke in furosemide initiatorsThanh Phuong Pham Nguyen, Sean Hennessy, Colleen M Brensinger, et al.
Journal of the American Heart Association|January 15, 2013
Relationship of plasma galectin-3 to renal function in patients with heart failure: effects of clinical status, pathophysiology of heart failure, and presence or absence of heart failureDeepa M Gopal, Maya Kommineni, Nir Ayalon, et al.
BMJ Open|February 23, 2021
Integrating Conservative kidney management Options and advance care Planning Education (COPE) into routine CKD care: a protocol for a pilot randomised controlled trialTaylor L Stallings, Jennifer S Temel, Tamar A Klaiman, et al.
Journal of the American Society of Nephrology : JASN|February 10, 2019
Cultivating a Research-Ready Dialysis CommunityJennifer E Flythe, Julia H Narendra, Tandrea Hilliard, et al.
Amyloid : the International Journal of Experimental and Clinical Investigation : the Official Journal of the International Society of Amyloidosis|January 10, 2006
Quantitative serum free light chain assay in the diagnostic evaluation of AL amyloidosisHarun Akar, David C Seldin, Barbarajean Magnani, et al.
Blood|May 25, 2004
Improvement in quality of life of patients with AL amyloidosis treated with high-dose melphalan and autologous stem cell transplantationDavid C Seldin, Jennifer J Anderson, Vaishali Sanchorawala, et al.
Journal of Vascular Surgery|April 2, 2014
Human type I pancreatic elastase treatment of arteriovenous fistulas in patients with chronic kidney diseaseRobert J Hye, Eric K Peden, Timothy P O'Connor, et al.
Clinical Journal of the American Society of Nephrology : CJASN|March 1, 2018
Clinical Trial End Points for Hemodialysis Vascular Access: Background, Rationale, and DefinitionsSurendra Shenoy, Michael Allon, Gerald Beathard, et al.
Contemporary Clinical Trials|September 1, 2025
Design and rationale of the SMaRRT-HD study: A pragmatic, randomized trial of symptom monitoring for individuals receiving maintenance hemodialysisJennifer E Flythe, Cassandra B Picataggio, Leah Bernardo, et al.
Pageof 14

Showing results (61-70 of 140) with videos related to

Sort By:
Pageof 14
Kidney International Reports|October 11, 2022
Efficacy, Safety, and Tolerability of Oral Furosemide Among Patients Receiving Hemodialysis: A Pilot StudyJennifer E Flythe, Magdalene M Assimon, Matthew J Tugman, et al.
British Journal of Clinical Pharmacology|May 4, 2026
Impact of empiric potassium supplementation on mortality, sudden cardiac arrest and stroke in furosemide initiatorsThanh Phuong Pham Nguyen, Sean Hennessy, Colleen M Brensinger, et al.
Journal of the American Heart Association|January 15, 2013
Relationship of plasma galectin-3 to renal function in patients with heart failure: effects of clinical status, pathophysiology of heart failure, and presence or absence of heart failureDeepa M Gopal, Maya Kommineni, Nir Ayalon, et al.
BMJ Open|February 23, 2021
Integrating Conservative kidney management Options and advance care Planning Education (COPE) into routine CKD care: a protocol for a pilot randomised controlled trialTaylor L Stallings, Jennifer S Temel, Tamar A Klaiman, et al.
Journal of the American Society of Nephrology : JASN|February 10, 2019
Cultivating a Research-Ready Dialysis CommunityJennifer E Flythe, Julia H Narendra, Tandrea Hilliard, et al.
Amyloid : the International Journal of Experimental and Clinical Investigation : the Official Journal of the International Society of Amyloidosis|January 10, 2006
Quantitative serum free light chain assay in the diagnostic evaluation of AL amyloidosisHarun Akar, David C Seldin, Barbarajean Magnani, et al.
Blood|May 25, 2004
Improvement in quality of life of patients with AL amyloidosis treated with high-dose melphalan and autologous stem cell transplantationDavid C Seldin, Jennifer J Anderson, Vaishali Sanchorawala, et al.
Journal of Vascular Surgery|April 2, 2014
Human type I pancreatic elastase treatment of arteriovenous fistulas in patients with chronic kidney diseaseRobert J Hye, Eric K Peden, Timothy P O'Connor, et al.
Clinical Journal of the American Society of Nephrology : CJASN|March 1, 2018
Clinical Trial End Points for Hemodialysis Vascular Access: Background, Rationale, and DefinitionsSurendra Shenoy, Michael Allon, Gerald Beathard, et al.
Contemporary Clinical Trials|September 1, 2025
Design and rationale of the SMaRRT-HD study: A pragmatic, randomized trial of symptom monitoring for individuals receiving maintenance hemodialysisJennifer E Flythe, Cassandra B Picataggio, Leah Bernardo, et al.
Pageof 14